<SEC-DOCUMENT>0001213900-17-010238.txt : 20171003
<SEC-HEADER>0001213900-17-010238.hdr.sgml : 20171003
<ACCEPTANCE-DATETIME>20171003140137
ACCESSION NUMBER:		0001213900-17-010238
CONFORMED SUBMISSION TYPE:	S-3/A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20171003
DATE AS OF CHANGE:		20171003

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-216748
		FILM NUMBER:		171117174

	BUSINESS ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-677-3875

	MAIL ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>fs32017a1_actiniumpharma.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM S-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on October 3, 2017 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-216748</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington,&nbsp;D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMENDMENT NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM S-3 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Actinium Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>88-0378336</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Identification Number)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>275 Madison Avenue, 7th Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>New York, New York 10016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(646) 677-3875</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address, including zip code, and telephone
number, including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Sandesh Seth</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Chairman and CEO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Actinium Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>275 Madison Avenue, 7th Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>New York, New York 10016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(646) 677-3875</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name, address, including zip code, and
telephone number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Copies of all communications, including
communications sent to agent for service, should be sent to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Thomas Slusarczyk, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>The Matt Law Firm, PLLC<BR>
1701 Genesee Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Utica,&nbsp;NY&nbsp;13501</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Tel. (315) 235-2299</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Fax (315) 624-7359</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt"><B>Approximate
date of commencement of proposed sale to the public:</B>&nbsp;From time to time after this Registration Statement becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If the only
securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the
following box:&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If any of
the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under
the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check
the following box:&nbsp;&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If this Form
is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, please check
the following box and list the Securities Act registration statement number of the earlier effective registration statement for
the same offering.&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If this Form
is a post-effective amendment filed pursuant to Rule&nbsp;462 I under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If this Form
is a registration statement filed pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become
effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If this Form
is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">Indicate by
check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 9pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#9744;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 9pt">Accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#9746;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 9pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#9744;</FONT><FONT STYLE="font-size: 9pt">&nbsp;&nbsp;(Do
    not check if a smaller reporting company)</FONT></TD>
    <TD><FONT STYLE="font-size: 9pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Emerging growth company</FONT></P></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&#9746;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 5pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 9pt">If an emerging
growth company, indicate by a checkmark if the registrant has elected not to use the extended period for complying with any new
or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &nbsp;&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>THE REGISTRANT HEREBY AMENDS THIS REGISTRATION
STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT
WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933, AS AMENDED, OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE SECURITIES
AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>This Amendment No. 1 to the Registration
Statement on Form S-3 (Registration No. 333-216748) by Actinium Pharmaceuticals, Inc. on March 16, 2017 (the &ldquo;Registration
Statement&rdquo;) is being filed solely for the purposes of amending Exhibit 5.1 and filing Exhibit 25.1. The prospectus is unchanged
and has been omitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10%"><B>Item 16.</B></TD><TD><B>Exhibits.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 1%">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1* </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriting Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1388320/000121390017002475/fs32017ex1ii_actiniumpharma.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At Market Issuance Sales Agreement, dated March 16, 2017, by and between Actinium Pharmaceuticals, Inc. and FBR Capital Markets &amp; Co.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1*</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
of Designation of Preferred Stock</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1388320/000121390014002309/fs32014a1ex4ii_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indenture (incorporated by reference to Form S-3/A Exhibit 4.2 filed on April 10, 2014)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1388320/000121390014002309/fs32014a1ex4iii_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Stock Warrant Agreement and Warrant Certificate (incorporated by reference to Form S-3/A Exhibit 4.3 filed on April 10, 2014)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1388320/000121390014002309/fs32014a1ex4iv_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Preferred Stock Warrant Agreement and Warrant Certificate (incorporated by reference to Form S-3/A Exhibit 4.4 filed on April 10, 2014)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1388320/000121390014002309/fs32014a1ex4v_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Debt Securities Warrant Agreement and Warrant Certificate (incorporated by reference to Form S-3/A Exhibit 4.5 filed on April 10, 2014)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6* </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Form of Subscription Rights Agreement and Certificate</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7* </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Form of Purchase Contract</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8* </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Form of Unit Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1***</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="fs32017a1ex5-1_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of The Matt Law Firm, PLLC</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1***</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs32017a1ex23-1_actinium.htm">Consent of GBH CPAs, PC</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2***</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="fs32017a1ex5-1_actinium.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of The Matt Law Firm, PLLC (included in Exhibit 5.1)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included in signature page)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1****</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form T-1 Statement of Eligibility and Qualification under the Trust Indenture Act of 1939</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; width: 0.5in">*</TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0">To be filed by amendment or as an exhibit to a Current Report of the registrant on Form 8-K or other document to be incorporated
herein by reference.</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding: 0; text-indent: 0">**</TD>
    <TD STYLE="padding: 0; text-indent: 0">Previously filed</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding: 0; text-indent: 0">***</TD>
    <TD STYLE="padding: 0; text-indent: 0">Filed herewith.</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding: 0; text-indent: 0">****</TD>
    <TD STYLE="padding: 0; text-indent: 0">To be filed separately pursuant to Section 305(b)(2) of the Trust Indenture Act of 1939, if applicable.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this amendment to registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of New York, State of New York, on October 3, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ACTINIUM PHARMACEUTICALS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Sandesh Seth</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Sandesh Seth</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chairman and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this amendment to registration statement has been signed by the following persons
in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                                         Sandesh Seth</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
        and Chief Executive Officer</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 3, 2017 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandesh Seth </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Steve O&rsquo;Loughlin</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
        Financial Officer</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 3, 2017 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve O&rsquo;Loughlin</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 3, 2017 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Nicholson </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
        Ajit Shetty</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 3, 2017 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ajit Shetty </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 3, 2017 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard I. Steinhart </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;By:
    </FONT></TD>
    <TD STYLE="width: 35%; text-decoration: none; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sandesh Seth</FONT></TD>
    <TD STYLE="width: 30%; text-decoration: none"></TD>
    <TD STYLE="width: 30%; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="text-decoration: none"></TD>
    <TD STYLE="text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</FONT></TD>
    <TD STYLE="text-decoration: none"></TD>
    <TD STYLE="text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; background-color: white">II-2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>fs32017a1ex5-1_actinium.htm
<DESCRIPTION>OPINION OF THE MATT LAW FIRM, PLLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-size: 10pt">October 3, 2017 </FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Actinium Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">275 Madison Avenue, 7th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We have acted as counsel to Actinium Pharmaceuticals,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;) with respect to the preparation of the Registration Statement on
Form S-3 (the &ldquo;<B>Registration Statement</B>&rdquo;) filed on the date hereof with the Securities and Exchange Commission
(the &ldquo;<B>Commission</B>&rdquo;) in connection with the registration by the Company under the Securities Act of 1933, as amended
(the &ldquo;<B>Securities Act</B>&rdquo;), of the offer and sale by the Company from time to time, pursuant to Rule 415 under the
Securities Act, of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(1) common stock, $0.001 par value per share,
of the Company (the &ldquo;<B>Common Stock</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(2) preferred stock, $0.001 par value per
share, of the Company (the &ldquo;<B>Preferred Stock</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(3) debt securities, in one or more series
(the <B>&ldquo;Debt Securities&rdquo;</B>), which may be issued pursuant to an indenture to be dated on or about the date of the
first issuance of Debt Securities thereunder, by and between the Company and a trustee to be selected by the Company (the <B>&ldquo;Indenture&rdquo;</B>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(4) warrants representing rights to purchase
Common Stock, Preferred Stock or Debt Securities (the &ldquo;<B>Warrants</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(5) rights to purchase shares of Common Stock
or Preferred Stock (the <B>&ldquo;Rights&rdquo;</B>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(6) purchase contracts relating to the sale
or purchase of securities by the Company (the <B>&ldquo;Purchase Contracts&rdquo;</B>); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">(7) units comprised of one or more shares
of Common Stock, Preferred Stock, Debt Securities or Warrants in any combination (the &ldquo;<B>Units</B>,&rdquo; and together
with the Common Stock, the Preferred Stock, the Debt Securities, the Rights, the Purchase Contracts, and the Warrants, the &ldquo;<B>Securities</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">with an aggregate offering price not to exceed $200,000,000.
Capitalized terms not defined herein shall have the meanings ascribed to them in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We also have acted as counsel to the Company
in connection with an offering of up to $75,000,000 of shares of Common Stock that may be issued and sold (the &ldquo;<B>Sales
Agreement Shares</B>&rdquo;) under an At Market Issuance Sales Agreement executed by the Company and FBR Capital Markets &amp;
Co. on March 14, 2017 (the &ldquo;<B>Sales Agreement</B>&rdquo;). The prospectus for the offer and sale of the Sales Agreement
Shares is included in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The opinions expressed herein are limited
exclusively to the General Corporation Law of the State of Delaware (the &ldquo;<B>DGCL</B>&rdquo;), applicable provisions of the
Delaware Constitution and judicial decisions interpreting the DGCL and applicable provisions of the Delaware Constitution, and
the federal laws of the United States of America, and we have not considered, and express no opinion on, any other laws or the
laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt; padding: 0pt 0pt 3pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In rendering the opinions expressed herein,
we have examined and relied upon the originals, or copies certified to our satisfaction, of (i) the Registration Statement; (ii)
the Company&rsquo;s Certificate of Incorporation and any amendments to date certified by the Secretary of State of the State of
Delaware; (iii) the Company&rsquo;s Bylaws and any amendments to date certified by an officer of the Company; (iv) the minutes
and records of the corporate proceedings of the Company with respect to the authorization of the filing of the Registration Statement
and the issuance of the Securities and related matters thereto; (v) the form of Sales Agreement; (vi) the form of common stock
certificate; and (vii) such other records, documents and instruments as we have deemed necessary for the expression of the opinions
stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In making such examination, we have assumed
the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies
and the authenticity of the originals of such latter documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In connection with this opinion, we have
assumed that: (i) the Registration Statement, and any further amendments thereto (including post-effective amendments) will have
become effective and comply with all applicable laws; (ii) a proper prospectus supplement or supplements (&ldquo;<B>Prospectus
Supplement</B>&rdquo;) will have been prepared and filed with the Commission describing the Securities offered thereby; (iii) all
Securities will be issued and sold in compliance with applicable federal and state securities laws and in the manner stated in
the Registration Statement and the appropriate Prospectus Supplement; (iv) a definitive purchase, underwriting or similar agreement,
or warrant or unit agreement, with respect to any Securities offered will have been duly authorized and validly executed and delivered
by the Company and the other parties thereto; (v) any Securities issuable upon conversion, exchange or exercise of any Security
being offered will be duly authorized, created and, if appropriate, reserved for issuance upon such conversion, exchange or exercise;
(vi) at the time of the issuance of any Securities, the Company will be a validly existing corporation under the law of its jurisdiction
of incorporation; (vii) the number of shares of Common Stock or Preferred Stock issued pursuant to the Registration Statement,
together with the number of shares outstanding or reserved at the time of issuance, will not exceed the respective number of shares
authorized by the Company&rsquo;s certificate of incorporation in effect at the time of such issuance; (viii) (a) no more than
327,868,852 shares of Common Stock will be sold under the Registration Statement and appropriate Prospectus Supplement assuming
a current market price of $0.61 per share, and (b) no more than 50,000,000 shares of Preferred Stock (the amount currently authorized
under the Company&rsquo;s Certificate of Incorporation, as amended) will be sold under the Registration Statement and appropriate
Prospectus Supplement, and (ix) all the foregoing actions to be taken by the Company are taken so as not to violate any applicable
law and so as to comply with any requirement or restriction imposed by any court or governmental or regulatory body having jurisdiction
over the Company or any of its property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Based on the foregoing, subject to the assumptions
and limitations stated herein, and having due regard for the legal considerations we deem relevant, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">1. When (i) the issuance and sale of any
shares of Common Stock have been duly authorized by all necessary corporate action of the Company and (ii) such shares have been
issued and delivered against payment of the purchase price therefor (in an amount in excess of the par value thereof) in accordance
with the applicable purchase, underwriting or other agreement, and as contemplated by the Registration Statement, such shares of
Common Stock will be validly issued, fully paid and nonassessable. The Common Stock covered in the opinion in this paragraph includes
any shares of Common Stock that may be issued upon exercise, conversion or exchange pursuant to the terms of any other Securities
but does not include the Sales Agreement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">2. When (i) the terms of any Preferred Stock
of a particular series and their issuance and sale have been duly authorized by all necessary corporate action of the Company,
(ii) a certificate of designations with respect to such series of Preferred Stock has been duly adopted by the Company and filed
with the Secretary of State of the State of Delaware, and (iii) such shares of Preferred Stock have been issued and delivered against
payment of the purchase price therefor (in an amount in excess of the par value thereof) in accordance with the applicable purchase,
underwriting or other agreement, and as contemplated by the Registration Statement, such shares of Preferred Stock will be validly
issued, fully paid, and nonassessable. The Preferred Stock covered in the opinion in this paragraph includes any shares of Preferred
Stock that may be issued upon exercise, conversion or exchange pursuant to the terms of any other Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt; padding: 0pt 0pt 3pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">3. When (i) the
terms of any Debt Securities of a particular series and their issuance and sale have been duly authorized by all necessary corporate
action of the Company, (ii)&nbsp;such Debt Securities have been duly executed and authenticated in accordance with the applicable
Indenture and issued and sold as contemplated in the Registration Statement, and (iii)&nbsp;the Company has received the consideration
provided for in the authorizing resolutions, such Debt Securities will constitute valid and legally binding obligations of the
Company, enforceable against the Company in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">4. When (i) the terms of any Warrants and
their issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii) such Warrants have
been duly executed, countersigned and delivered in accordance with the applicable warrant agreement and against payment of the
purchase price therefor in accordance with the applicable purchase, underwriting or other agreement, and as contemplated by the
Registration Statement, such Warrants will constitute valid and binding obligations of the Company enforceable against the Company
in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">5. When (i) the terms of any Rights and their
issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii) such Rights have been duly
executed, countersigned and delivered in accordance with the applicable rights agreement and against payment of the purchase price
therefor in accordance with the applicable purchase, underwriting or other agreement, and as contemplated by the Registration Statement,
such Rights will constitute valid and binding obligations of the Company enforceable against the Company in accordance with their
terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">6. When (i) the terms of any Purchase Contracts
and their issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii) such Purchase Contracts
have been duly executed, countersigned and delivered in accordance with the applicable purchase contract agreement and against
payment of the purchase price therefor in accordance with the applicable purchase, underwriting or other agreement, and as contemplated
by the Registration Statement, such Purchase Contracts will constitute valid and binding obligations of the Company enforceable
against the Company in accordance with their terms; however, we express no opinion regarding any securities subject to the Purchase
Contracts which are not securities issued by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">7. When (i) the terms of any Units and their
issuance and sale have been duly authorized by all necessary corporate action of the Company and (ii) such Units have been duly
executed, countersigned and delivered in accordance with the applicable unit agreement and against payment of the purchase price
therefor in accordance with the applicable purchase, underwriting or other agreement, and as contemplated by the Registration Statement,
such Units will constitute valid and binding obligations of the Company enforceable against the Company in accordance with their
terms; however, we express no opinion regarding any securities comprising the Units which are not securities issued by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">8. The Sales Agreement Shares are duly authorized
and, when such shares have been issued and delivered against payment of the purchase price therefor (in an amount in excess of
the par value thereof) in accordance with the Sales Agreement, and as contemplated by the Registration Statement, the Sales Agreement
Shares will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Our opinion that any document is legal, valid
and binding is qualified as to: (i) limitations imposed by bankruptcy, insolvency, reorganization, arrangement, fraudulent conveyance,
moratorium or other laws relating to or affecting the rights of creditors generally; (ii) rights to indemnification and contribution,
which may be limited by applicable law or equitable principles; and (iii) general principles of equity, including without limitation
concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or
injunctive relief and limitation of rights of acceleration, regardless of whether such enforceability is considered in a proceeding
in equity or at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt; padding: 0pt 0pt 3pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement and to all references to us in the Registration Statement. In giving this consent,
we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ The Matt Law Firm, PLLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fs32017a1ex23-1_actinium.htm
<DESCRIPTION>CONSENT OF GBH CPAS, PC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-right: 0; margin-left: 0"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">We hereby consent to the incorporation by reference in this
Registration Statement of Actinium Pharmaceuticals, Inc. on Form S-3/A of our report dated March 16, 2017 relating to the consolidated
financial statements of Actinium Pharmaceuticals, Inc. as of December 31, 2016 and 2015 and for the years then ended. We also consent
to the reference to our firm under the headings &quot;Experts&quot; appearing therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">/s/ GBH CPAs, PC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">GBH CPAs, PC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">www.gbhcpas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Houston, Texas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !J KT# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-\/>"]%A\.:W>Z#X \.ZUX4T?2K[Q!>W-G#INL>=_:,#HTG[SSA,06;+ )&
M1L7 !K_\$]O^"D6F_P#!06VURYTOP+XP\*6&G:?I>L6-[JMOBUU2UU")Y8E2
M4 +]HB$>)HE+B,O'\[;CCYU^'W_!3KQW\,O^"I_Q'\'_ !$U8ZA\'O$NCZG<
M_#&SCLK5=0N-2TG4(M.O=/B:-$>XEFN6E$*,S-A4!.<L?MSX#_LS^'/V</A5
M:^#?#-QXB71["PBTRS-_K-Q?7%E:PQ^7!#%),[%%B3Y5 ],G)R3Q.A?\$W/A
M7H4W@B\_LO5K_7OAO'K2^&=;OM5GNM3T>35SNOIHYG8DS.<D2,&9"S%<;CD
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MO^DIV2OTT_X)<_MP:?\ \%$_V$_A[\6+,VL=]X@TY8]9M8&RMAJ4),5W#CJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*,UQ?QZ^.&G_ +/_ ((MM<U#3]4U1+W5M/T6WM-.$37,]S>W4=K JB1T4YEE
M3/S?*NYNBFH?%?[06@^"?C#X=\%:HWV/4O$UG-=6<TUU;QPEHV5?(PT@D:5M
MQ*A$8$1R$D;>0#ATUJ/QQ_P4"NK6WU:9;/P#X'_TRUCU%Q";K4;SY&:#=L\R
M&&P;YRNY1=CD!@#XAI?P[M_"?P.U'XD>&8?$'A-?BMJ^E:#9W,6H7;3:)X<N
M=1B1]1E,TF8[J>!WF:<X:'S81D&)F;[$\-?$C0_%M@EU8W\+127USID9E5H&
MEN+>:2&:-%D"LVV2)QE00P7()&#6I8:M::N)OLMS;W7V>0PS>5('\MQU1L'A
MAD<'GF@#XNU*[:^\+3:+IU]K6B>'_BC\7--L/"=N-3FM&32+&*T>]GA.\/\
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MV!=H'0UZY7C_ /PW[\&/^BC^&?\ P)_^M1_PW[\&/^BC^&?_  )_^M0!S/\
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M8_Z*/X9_\"?_ *U 'L%%>/\ _#?OP8_Z*/X9_P# G_ZU'_#?OP8_Z*/X9_\
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MIU#5OAWXYL3;:7=>)+RZG_L6^U2^-S92P#5;2]M(W@$0*+##I]A$,LQ1H&V
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MOO$NG:7I#:A=7]E;V"0FX:YEG5(5B W%RY.-N.<YQCFOS@^'FE_"3]E_Q_\
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M_P!I']G/X=Z]XAL='T^#QJOCKQ%)/*8XK6TTJTN)[,2MC:OF:D;(H&(+>2^
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M'%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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5J#UU5"*%4!57@ =J6B@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
